Stanislav Glezer - 01 Mar 2022 Form 4 Insider Report for Inogen Inc (INGN)

Role
EVP, Chief Medical Officer
Signature
/s/ Leslyn Cicekli, as Attorney-in-Fact
Issuer symbol
INGN
Transactions as of
01 Mar 2022
Net transactions value
$0
Form type
4
Filing time
03 Mar 2022, 19:54:47 UTC
Previous filing
11 Aug 2021
Next filing
12 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INGN Restricted Stock Unit Award $0 +11,360 $0.000000 11,360 01 Mar 2022 Common Stock 11,360 Direct F1, F2
transaction INGN Restricted Stock Unit Award $0 +11,360 $0.000000 11,360 01 Mar 2022 Common Stock 11,360 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
F2 Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date.
F3 Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on December 1, 2022, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date.